| Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label … TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G Castro, ... The Lancet 393 (10183), 1819-1830, 2019 | 2880 | 2019 |
| The role of inflammation in lung cancer M Gomes, AL Teixeira, A Coelho, A Araujo, R Medeiros Inflammation and cancer, 1-23, 2014 | 284 | 2014 |
| FGFR a promising druggable target in cancer: Molecular biology and new drugs R Porta, R Borea, A Coelho, S Khan, A Araújo, P Reclusa, T Franchina, ... Critical reviews in oncology/hematology 113, 256-267, 2017 | 245 | 2017 |
| Immunotherapy in NSCLC: a promising and revolutionary weapon C Rolfo, C Caglevic, M Santarpia, A Araujo, E Giovannetti, CD Gallardo, ... Immunotherapy, 97-125, 2017 | 130 | 2017 |
| Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer—a review of the literature A Araujo, R Ribeiro, I Azevedo, A Coelho, M Soares, B Sousa, D Pinto, ... The oncologist 12 (2), 201-210, 2007 | 126 | 2007 |
| Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice S Taverna, M Giallombardo, I Gil-Bazo, AP Carreca, M Castiglia, ... Oncotarget 7 (19), 28748, 2016 | 117 | 2016 |
| A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer R Ribeiro, AP Araújo, A Coelho, R Catarino, D Pinto, A Araújo, C Calçada, ... European Journal of Cancer 42 (8), 1188-1193, 2006 | 89 | 2006 |
| Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients R Catarino, A Coelho, A Araújo, M Gomes, A Nogueira, C Lopes, ... PloS one 7 (6), e38559, 2012 | 79 | 2012 |
| Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies RA de Mello, DS Marques, R Medeiros, AMF Araújo World Journal of Clinical Oncology 2 (11), 367, 2011 | 74 | 2011 |
| HER2 therapies and gastric cancer: a step forward RA de Mello, AM Marques, A Araújo World journal of gastroenterology: WJG 19 (37), 6165, 2013 | 60 | 2013 |
| High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer JG Guedes, I Veiga, P Rocha, P Pinto, C Pinto, M Pinheiro, A Peixoto, ... BMC cancer 13, 1-10, 2013 | 58 | 2013 |
| Burnout and occupational stress in the medical residents of Oncology, Haematology and Radiotherapy: a prevalence and predictors study in Portugal A Joaquim, S Custódio, J Savva-Bordalo, S Chacim, I Carvalhais, ... Psychology, health & medicine 23 (3), 317-324, 2018 | 53 | 2018 |
| : P2-235: Optimal duration of chemotherapy in non-small-cell lung cancer: multicenter, randomized, prospective clinical trial comparing 4 vs 6 cycles of carboplatin and gemcitabine FJ Barata, B Parente, E Teixeira, F Nogueira, A Fernandes, J Cunha, ... Journal of Thoracic Oncology 2 (8), S666, 2007 | 46 | 2007 |
| Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer P Pinto, P Rocha, I Veiga, J Guedes, M Pinheiro, A Peixoto, C Pinto, ... Cancer Genetics 204 (8), 439-446, 2011 | 45 | 2011 |
| Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches? AL Coelho, MP Gomes, RJ Catarino, C Rolfo, AM Lopes, RM Medeiros, ... Oncotarget 8 (24), 39795, 2017 | 44 | 2017 |
| Exosomes genetic cargo in lung cancer: a truly Pandora’s box P Reclusa, R Sirera, A Araujo, M Giallombardo, A Valentino, L Sorber, ... Translational lung cancer research 5 (5), 483, 2016 | 44 | 2016 |
| Comparative efficacy of ceritinib and crizotinib as initial ALK–targeted therapies in previously treated advanced NSCLC: an adjusted comparison with external controls DSW Tan, A Araújo, J Zhang, J Signorovitch, ZY Zhou, X Cai, G Liu Journal of Thoracic Oncology 11 (9), 1550-1557, 2016 | 42 | 2016 |
| Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives I Marques, A Araújo, RA de Mello World Journal of Gastroenterology: WJG 19 (44), 7955, 2013 | 42 | 2013 |
| Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator? R Ribeiro, A Araújo, C Lopes, R Medeiros Journal of Thoracic Oncology 2 (2), 105-108, 2007 | 41 | 2007 |
| IL-6 polymorphism in non-small cell lung cancer: a prognostic value? M Gomes, A Coelho, A Araujo, A Azevedo, AL Teixeira, R Catarino, ... Tumor Biology 36, 3679-3684, 2015 | 40 | 2015 |
